News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi Pasteur (SASY.PA)’s Patents on Cancer Drug Taxotere Invalidated; Paving the Way for Hospira, Inc. (HSP) and Apotex Corp. to Start Selling Generic Versions


9/28/2010 7:48:34 AM

Bloomberg -- Sanofi-Aventis SA’s patents on its cancer drug Taxotere were ruled invalid by a U.S. judge, potentially clearing the way for Hospira Inc. and Apotex Inc. to start selling generic versions of the medicine.

Read at Bloomberg
Read at News Release
Read at Forbes
Read at Seeking Alpha

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES